Nemaura Medical, Inc.'s next confirmed earnings release is scheduled for November 17, 2026.
| Earnings Date | 11/17/2026 |
As of December 31, 2023, Nemaura Medical, Inc. has 28.90M shares outstanding.
| Shares Outstanding | 28.90M |
As of December 31, 2023, Nemaura Medical, Inc. maintains a current ratio of 0.19, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -110.19, indicating conservative leverage, while an interest coverage ratio of -1.63 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.19 |
| Quick Ratio | 0.02 |
| Debt / Equity | -110.19 |
| Debt / EBITDA | -2.13 |
| Interest Coverage | -1.63 |
These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) is negative at -117.49, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 38.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.49 indicates how many times Nemaura Medical, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -117.49 |
| Employee Count | 38.00 |
| Inventory Turnover | 0.49 |
As of the close on November 16, 2026, Nemaura Medical, Inc.'s stock has declined approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | -50.00% |
Over the twelve months ended December 31, 2023, Nemaura Medical, Inc. generated - - in revenue and converted that into -10.65M in net income, yielding earnings per share of -0.38. EBITDA reached -9.23M, while operating income came in at -8.96M.
| Gross Profit | -1.48M |
| Operating Income | -8.96M |
| Pretax Income | -10.65M |
| Net Income | -10.65M |
| EBITDA | -9.23M |
| EBIT | -9.71M |
| Earnings Per Share (EPS) | -0.38 |
As of December 31, 2023, Nemaura Medical, Inc. holds 137,416.00 in cash and equivalents against 19.64M in total debt, resulting in a net debt position of 19.51M. Total book value stands at -17.83M, with working capital of -18.62M providing operational flexibility.
| Cash & Cash Equivalents | 137,416.00 |
| Total Debt | 19.64M |
| Net Debt | 19.51M |
| Equity (Book Value) | -17.83M |
| Book Value Per Share | -0.62 |
| Working Capital | -18.62M |
Nemaura Medical, Inc. produced -9.57M in operating cash flow over the twelve months ended December 31, 2023. After subtracting -177,219.00 in capital expenditures, free cash flow totaled -9.74M - equivalent to -0.34 per share.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -177,219.00 |
| Free Cash Flow | -9.74M |
| FCF Per Share | -0.34 |
Nemaura Medical, Inc.'s most recent stock split took place on December 5, 2019 with a 10:1 split ratio.
| Last Split Date | 12/5/2019 |
| Split Ratio | 10:1 |